6505NCM249981: SUMATRIPTAN SUCCINATE TABLETS.
The SUMATRIPTAN SUCCINATE TABLETS is a the manufacturer industrial component. Key specifications include administration: ORAL, features_provided: ENTERIC COATED, primary_container_type: BOTTLE, primary_container_content_quantity: 9.0 TABLETS, active_medicament_medicinal_strength: 25.0 MILLIGRAMS SUMATRIPTAN SUCCINATE ACTIVE INGREDIENT, part_name_assigned_by_controlling_agency: SUMATRIPTAN SUCCINATE TABLETS, 25 MG, 9S. This part is cataloged in the U.S.
Government catalog under NSN 6505-01-724-6289, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| administration | ORAL |
| features_provided | ENTERIC COATED |
| primary_container_type | BOTTLE |
| primary_container_content_quantity | 9.0 TABLETS |
| active_medicament_medicinal_strength | 25.0 MILLIGRAMS SUMATRIPTAN SUCCINATE ACTIVE INGREDIENT |
| part_name_assigned_by_controlling_agency | SUMATRIPTAN SUCCINATE TABLETS, 25 MG, 9S |
| NSN | 6505-01-724-6289 |
| ADMINISTRATION | ORAL |
| PRIMARY CONTAINER CONTENT QUANTITY | 9.0 TABLETS |
| FEATURES PROVIDED | ENTERIC COATED |
| PRIMARY CONTAINER TYPE | BOTTLE |
| SPECIAL FEATURES | INDICATED FOR THE ACUTE TREATMENT OF MIGRAINE WITH OR WITHOUT AURA IN ADULTS; STORE AT 20 TO 25 C (68 TO 77 F). (SEE USP CONTROLLED ROOM TEMPERATURER). PROTECT FROM LIGHT; BOTTLE OF 9 TABLETS; FILM COATED, 25MG TABLET. |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | SUMATRIPTAN SUCCINATE TABLETS, 25 MG, 9S |
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | 25.0 MILLIGRAMS SUMATRIPTAN SUCCINATE ACTIVE INGREDIENT |